Safety and Immunogenicity of Typhax, a Typhoid Vaccine

NCT03926455 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Matrivax Research and Development Corporation